Lancet Oncology writes on India’s dextropropoxyphene ban
India urged to reverse dextropropoxyphene ban
Dinesh C Sharma; Lancet Oncology, Early Online Publication, 5 July 2013
Palliative care experts have urged the Indian Ministry of Health to reverse its decision to ban the manufacture and sale of dextropropoxyphene and formulations that contain it. The ban on the cheapest opioid available for oral use could increase the pain burden of patients with cancer who cannot afford costly alternatives….